Pathologic characteristics of human T-cell lymphotropic virus (HTLV)-related extranodal orofacial lymphomas. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Pathologic characteristics of human T-cell lymphotropic virus (HTLV)-related extranodal orofacial lymphomas.

Oral Surg Oral Med Oral Pathol. 1990 Aug;70(2):199-205. Unique Identifier : AIDSLINE MED/91149034
Kurihara K; Kohno H; Miyamoto N; Chikamori Y; Kondo T; Department of Pathology, Uwajima City Hospital, Japan.

Abstract: Eleven cases of extranodal orofacial lymphomas (EOFL), consisting of four HTLV-related and seven HTLV-unrelated EOFL, were investigated with respect to the immunohistochemical and clinical features. HTLV-related EOFL were of T-cell phenotype and were associated with a poorer prognosis than HTLV-unrelated EOFL, most of which were of B-cell origin. The appearance of giant cells with cerebriform nuclei was helpful in identifying HTLV-related EOFL. The relatively high incidence of T-cell type EOFL in our series was considered to be related to the high percentage of HTLV carriers in our district, an area endemic for adult T-cell leukemia-lymphoma.
Keywords: Adult Aged Aged, 80 and over B-Lymphocytes/PATHOLOGY Cell Nucleus/ULTRASTRUCTURE Facial Neoplasms/*PATHOLOGY Female Human HTLV-I HTLV-I Infections/*PATHOLOGY Lymphoma/*PATHOLOGY Male Middle Age Mouth Neoplasms/*PATHOLOGY T-Lymphocytes/PATHOLOGY JOURNAL ARTICLEKWDadultagedaged,80andoverb-lymphocytes/pathologycellnucleus/ultrastructurefacialneoplasms/KWDpathologyfemalehumanhtlv-ihtlv-iinfections/KWDpathologylymphoma/KWDpathologymalemiddleagemouthneoplasms/KWDpathologyt-lymphocytes/pathologyjournalarticle
910630
M9160672

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .